Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose spironolactone effectively treats female pattern hair loss with mild side effects.

Taking 2.5mg of finasteride daily can effectively improve hair loss in 62% of women, especially those pre-menopause or with less severe hair loss.

Flutamide effectively treats female pattern hair loss long-term with low doses being safe for the liver.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

The 5% minoxidil lotion without propylene glycol is effective, well-tolerated, and cosmetically acceptable for hair loss.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Hair loss may indicate higher risk of heart disease.

Oral minoxidil improved hair loss more than oral dutasteride.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

AI can accurately measure hair loss severity in alopecia areata.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

Regenera Activa AMT effectively improves hair growth and reduces hair loss in androgenetic alopecia.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

PRP therapy can improve hair growth in early to moderate hair loss but needs standardized methods for consistent results.

The author believes that giving medical conditions official names can sometimes overwhelm or scare patients.

Oral minoxidil is an effective alternative for hair loss but may cause more unwanted hair growth.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Low vitamin D might be one of several factors involved in the hair loss condition alopecia areata.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Ayurvedic treatment improved hair condition and density safely in a woman with hair loss.

The 2940-nm Er: YAG laser combined with medication is a safe and better treatment for male hair loss than medication alone.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Vitamin D3 analogs can promote hair growth in mice genetically prone to hair loss.